Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1983-07-29
1985-12-31
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544 22, A61K 31545, C07D50124
Patent
active
045621810
ABSTRACT:
There is described a product which is a highly pure substantially amorphous form of cefuroxime axetil (cefuroxime 1-acetoxyethyl ester) which is stable, which has increased absorption via the gastro-intestinal tract and has a correspondingly high level of bioavailability on oral or rectal administration.
Methods of preparing the product are also described which involve the recovery of the product from a solution thereof. A preferred method is the use of spray drying techniques, though roller drying, solvent precipitation or freeze-drying are also described.
Also disclosed are pharmaceutical compositions containing the product and methods for its use in medicine.
REFERENCES:
patent: 4267320 (1981-05-01), Gregson et al.
patent: 4444686 (1984-04-01), Jasys
Sato et al, Chem. Pharm. Bull., 29(9), 2675-2682 (1981).
Masters et al, "Aseptic and Closed Cycle Spray Drying in Pharmaceutical/Biochemicals Manufacture", in Process Biochemistry, Jan./Feb., 1975.
Ripple, "Remingtons Pharmaceutical Sciences", Chap. 88, pp. 1535-1552.
Clayton John C.
Crisp Harold A.
Benson Robert
Daus Donald G.
Glaxo Group Limited
LandOfFree
Amorphous form of cefuroxime ester does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amorphous form of cefuroxime ester, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amorphous form of cefuroxime ester will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1024874